10x Genomics acquired Proteintech Genomics, a division of Proteintech Group specializing in single-cell and spatial proteomic solutions. This strategic expansion integrates transcriptomic and proteomic analysis into a single platform.
The deal brings Proteintech’s Human Discovery Panel in-house, currently the largest antibody-based panel for single-cell analysis. Researchers can now simultaneously analyze RNA and proteins within the same workflow to advance immunology and oncology research.
Financial terms of the acquisition remain undisclosed. 10x Genomics expects no meaningful impact on its near-term financial outlook from this transaction.